Could this Healthcare Stock really climb 135.99% by 2024?

Earnings Alert. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Lithium Discovery So BIG You Can't Miss it, Even From Space]( [Free Investor Report Reveals Ambitious Plan To Meet Lithium Demand]( --------------------------------------------------------------- November 30, 2023 (Earnings Report) From the desk of the Editor Dear Reader, We just identified several stocks that are expected to release earnings very soon. If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments. Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements. --------------------------------------------------------------- Sponsor Message [Recent Reports Are A Wake-Up Call For Investors]( the demand for lithium, an essential element to the energy revolution, increases globally, researchers are projecting a supply deficit as early as 2025. This has sparked a worldwide "gold rush" to find and develop new sources of this critical metal. Savvy investors are paying attention as mining companies race to meet this critical deadline. [Meet A Young Company With A Massive Project In Our Backyard - Must See Report]( --------------------------------------------------------------- [Bank Of Montreal]( Symbol: [BMO]( Recent Price: $81.01 Average Analyst Price Target: $93.30 (15.64%) Market Cap: $57.78B Last Year's EPS: $2.16 Consensus EPS Forecast: $2.28 Expected Earnings Date: Dec 01 2023 Recent Analyst Action: Mike Rizvanovic, analyst at KBW, reiterates coverage on [Bank Of Montreal (BMO)]( in the Financial sector with a Buy rating and a price target of $94.48 (6 days ago). [TipRanks.com]( also reports that [Bank Of Montreal]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $93.30 . The target pricing ranges from a high forecast of $99.65 down to a low forecast of $84.89. [Bank Of Montreal (BMO)](’s last closing price was $81.01 which would put the average price target at 15.64% upside. Here are 3rd party ratings for [BMO](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: sell - Zacks.com: Sell, Bottom 33% (167 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Musk: My new robots could be bigger than Tesla]( No one can deny Elon Musk is a visionary. But has he finally gone too far? [>>See the shocking future of AI here<<]( --------------------------------------------------------------- [Genesco]( Symbol: [GCO]( Recent Price: $37.24 Average Analyst Price Target: $38.00 (2.04%) Market Cap: $372.32M Last Year's EPS: -$1.59 Consensus EPS Forecast: -$1.23 Expected Earnings Date: Dec 01 2023 Recent Analyst Action: Mitch Kummetz, analyst at Seaport Global, reiterates coverage on [Genesco (GCO)]( in the Consumer Cyclical sector with a Buy rating and a price target of $38 (2 months ago). [TipRanks.com]( also reports that [Genesco]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $38.00 . The target pricing ranges from a high forecast of $38 down to a low forecast of $38. [Genesco (GCO)](’s last closing price was $37.24 which would put the average price target at 2.04% upside. Here are 3rd party ratings for [GCO](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Strong Buy, Bottom 44% (141 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Tanzanian Royalty Exploration]( Symbol: [TRX]( Recent Price: $0.42 Average Analyst Price Target: $1.30 (213.18%) Market Cap: $108.49M Last Year's EPS: -$0.00018 Consensus EPS Forecast: -$0.00066 Expected Earnings Date: Dec 01 2023 Recent Analyst Action: Heiko Ihle, analyst at H.C. Wainwright, reiterates coverage on [Tanzanian Royalty Exploration (TRX)]( in the Basic Materials sector with a Buy rating and a price target of $1.3 (1 month ago). [TipRanks.com]( also reports that [Tanzanian Royalty Exploration]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $1.30 . The target pricing ranges from a high forecast of $1.3 down to a low forecast of $1.3. [Tanzanian Royalty Exploration (TRX)](’s last closing price was $0.42 which would put the average price target at 213.18% upside. Here are 3rd party ratings for [TRX](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Strong Sell, Top 32% (81 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [My Gift to You]( I have arranged for you to receive [a complimentary 3-month subscription]( to Bernie Schaeffer’s Option Advisor online newsletter. [CLICK HERE]( for 3 Months FREE of Bernie Schaeffer’s Option Advisor ($395 Retail Value - [FREE!]() --------------------------------------------------------------- [OKYO Pharma Limited Sponsored ADR]( Symbol: [OKYO]( Recent Price: $1.70 Average Analyst Price Target: $4.00 (135.99%) Market Cap: $47.00M Last Year's EPS: $0 Consensus EPS Forecast: -$0.11 Expected Earnings Date: Dec 01 2023 Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on [OKYO Pharma Limited Sponsored ADR (OKYO)]( in the Healthcare sector with a Buy rating and a price target of $4 (3 weeks ago). [TipRanks.com]( also reports that [OKYO Pharma Limited Sponsored ADR]( currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $4.00 . The target pricing ranges from a high forecast of $4 down to a low forecast of $4. [OKYO Pharma Limited Sponsored ADR (OKYO)](’s last closing price was $1.70 which would put the average price target at 135.99% upside. Here are 3rd party ratings for [OKYO](: - TipRanks.com: Moderate Buy - TradingView.com: Neutral - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: n/a, n/a [Click for chart >>]( -------------------------------------------------------------------------- [Nio]( Symbol: [NIO]( Recent Price: $7.18 Average Analyst Price Target: $15.38 (89.55%) Market Cap: $12.56B Last Year's EPS: -$0.42 Consensus EPS Forecast: -$0.36 Expected Earnings Date: Dec 04 2023 Recent Analyst Action: Tim Hsiao, analyst at Morgan Stanley, reiterates coverage on [Nio (NIO)]( in the Consumer Cyclical sector with a Buy rating and a price target of $18.7 (3 weeks ago). [TipRanks.com]( also reports that [Nio]( currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $15.38 . The target pricing ranges from a high forecast of $8 down to a low forecast of $15. [Nio (NIO)](’s last closing price was $7.18 which would put the average price target at 89.55% upside. Here are 3rd party ratings for [NIO](: - TipRanks.com: Moderate Buy - TradingView.com: Sell - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: Buy, Top 15% (37 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Silicon Valley Is Buzzing About This $5 Stock Behind The "Apple Car"]( insider's Silicon Valley pals are going crazy over this $5 stock behind the Apple Car… and his analysis indicates it could turn every $500 invested into $20,000 once the Apple Car goes live! [Click here to see how to take advantage of this incredible opportunity.]( --------------------------------------------------------------- [Gitlab]( Symbol: [GTLB]( Recent Price: $48.60 Average Analyst Price Target: $56.50 (21.03%) Market Cap: $7.22B Last Year's EPS: -$0.06 Consensus EPS Forecast: -$0.03 Expected Earnings Date: Dec 04 2023 Recent Analyst Action: Adam Tindle, analyst at Raymond James, reiterates coverage on [Gitlab (GTLB)]( in the Technology sector with a Hold rating (1 day ago). [TipRanks.com]( also reports that [Gitlab]( currently has 4 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $56.50 . The target pricing ranges from a high forecast of $65 down to a low forecast of $50. [Gitlab (GTLB)](’s last closing price was $48.60 which would put the average price target at 21.03% upside. Here are 3rd party ratings for [GTLB](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 14% (34 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- [Science Applications]( Symbol: [SAIC]( Recent Price: $115.97 Average Analyst Price Target: $113.80 (-1.87%) Market Cap: $6.16B Last Year's EPS: $2.14 Consensus EPS Forecast: $1.6 Expected Earnings Date: Dec 04 2023 Recent Analyst Action: Cai von, analyst at TD Cowen, reiterates coverage on [Science Applications (SAIC)]( in the Technology sector with a Buy rating and a price target of $120 (2 months ago). [TipRanks.com]( also reports that [Science Applications]( currently has 5 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $113.80 . The target pricing ranges from a high forecast of $120 down to a low forecast of $103. [Science Applications (SAIC)](’s last closing price was $115.97 which would put the average price target at -1.87% upside. Here are 3rd party ratings for [SAIC](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Buy, Top 20% (49 out of 251) [Click for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Countries Are Investing Heavily Into Securing Energy Independence]( s a worldwide "arms race" for countries to secure lithium - the critical metal essential to powering the world's green energy transition. While the U.S. is now investing heavily into lithium production, the North American supply chain has fallen far behind. One company is on a mission to change that and make a previously remote area the next great lithium mining hub. [Learn more about this young company pioneering an incredible potential supply of lithium.]( --------------------------------------------------------------- And there you have it--- Stocks expected to release earnings soon... Sincerely, The Editor, MarketInsidersPress.com MarketInsidersPress.com Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. [If you are not a human, click here.]( By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to MarketInsidersPress.com MarketInsidersPress.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville NC | 28115 MarketInsidersPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy | Unit 4 | Mount Mourne | NC | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software